COVID-19 Testing & Treatment

Everyone is a VIP at Frontline ER!

Frontline ER offers the latest in COVID-19 testing, and we now offer Monoclonal Antibody Treatment, the same COVID-19 treatment former President Trumpreceived when he was diagnosed with COVID-19.

Fontline ER COVID-19 Treatment


We currently accept most commercial insurances for ALL Covid-Related Tests at no charge to the patient.

Our tests include:

20 minute results:

  • Rapid Antigen Test (Nasal Swab)
  • Antibody Test (Blood Draw)
  • Influenza A & B (Nasal Swab)
  • Strep Test (Throat Swab)

3-5 day results:

  • PCR Test (Nasal Swab)

Uninsured out-of-pocket pricing is available,  please call the facility for more information.

We do accept MEDICARE, but are unable to accept Medicaid or Tricare.

Tests for travel are not covered under insurance.  Please check with your travel/agency to determine which type test is acceptable for your needs.

Questions about COVID-19 and your insurance claims? (.pdf download)

Fontline ER COVID-19 Test


As the battle against COVID-19 continues, science continues to find and use new and more effective treatments against the virus.

If you are high-risk and meet certain criteria, Frontline ER has a treatment option for you.  It’s called Monoclonal Antibody Treatment, mAb for short, and it’s available now.

If you test positive for COVID-19 and meet certain criteria, you can be treated with mAb. This is the same treatment that was given to former President Trump when he was hospitalized for COVID-19.

There is mounting new data that this treatment will reduce the amount of hospitalizations needed from COVID-19.

To be administered this treatment, you must meet the following criteria and be prepared to stay overnight for observation:

  • A body mass index (BMI) greater than 35
  • Suffer from chronic kidney disease, diabetes or an immunosuppressive disease
  • Be receiving treatment for any of the above
  • Are 65 or older
  • Or are at least 55 and suffer from cardiovascular disease, hypertension or chronic pulmonary disease
  • Are 12 to 17 with a BMI in the 85th percentile for their age and gender and suffer from a specific list of diseases, most prominently congenital heart disease or asthma.
  • Not have received the COVID-19 vaccine within the past 90days.

How is mAb administered? 

  • Casirivimab and imdevimab are two investigational medicines given together as a single intravenous infusion (through a vein) for at least 1 hour with an additional 1-2 hours for observation.
  • You will receive one dose of casirivimab and imdevimab by intravenous infusion. 

Want to learn more? 

Patient Fact Sheet (.pdf)